These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21170913)

  • 1. Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods.
    Sweeting MJ; De Angelis D; Parry J; Suligoi B
    Stat Med; 2010 Dec; 29(30):3194-202. PubMed ID: 21170913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixture models for calibrating the BED for HIV incidence testing.
    Mahiane SG; Fiamma A; Auvert B
    Stat Med; 2014 May; 33(10):1767-83. PubMed ID: 24834521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 infection among Ethiopian immigrants to Israel: enhanced in vitro antibody stimulation for estimating the length of the window period.
    Novikov I; Jehuda-Cohen T
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):165-74. PubMed ID: 19239355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the distribution of infection times using longitudinal serological markers of HIV: implications for the estimation of HIV incidence.
    Sommen C; Commenges D; Vu SL; Meyer L; Alioum A
    Biometrics; 2011 Jun; 67(2):467-75. PubMed ID: 20731647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes.
    Chu H; Cole SR
    Biom J; 2006 Aug; 48(5):772-9. PubMed ID: 17094342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.
    Stirrup OT; Dunn DT
    BMC Med Res Methodol; 2018 Jun; 18(1):65. PubMed ID: 29945571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of IgG3 antibodies specific to the human immunodeficiency virus type 1 (HIV-1) p24 protein as marker for recently acquired infection.
    Viana IFT; Coêlho DF; Palma ML; Nascimento EJM; Gu G; Lima LFO; Foti L; Krieger MA; Pilcher C; Calzavara-Silva CE; Mailliard RB; Rinaldo CR; Dhalia R; Marques ETA
    Epidemiol Infect; 2018 Jul; 146(10):1293-1300. PubMed ID: 29925445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
    Cousins MM; Konikoff J; Sabin D; Khaki L; Longosz AF; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Kobin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    PLoS One; 2014; 9(6):e101043. PubMed ID: 24968135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.
    Romero-Severson EO; Lee Petrie C; Ionides E; Albert J; Leitner T
    Int J Epidemiol; 2015 Jun; 44(3):998-1006. PubMed ID: 26163684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accidental Father-to-Son HIV-1 Transmission During the Seroconversion Period.
    Ezeonwumelu I; Bártolo I; Martin F; Abecasis A; Campos T; Romero-Severson EO; Leitner T; Taveira N
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):857-862. PubMed ID: 30073842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative interpretation of Sedia LAg Assay test results after HIV diagnosis.
    Sempa JB; Grebe E; Welte A
    PLoS One; 2022; 17(7):e0271763. PubMed ID: 35901053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A top scoring pairs classifier for recent HIV infections.
    Chen A; Laeyendecker O; Eshleman SH; Monaco DR; Kammers K; Larman HB; Ruczinski I
    Stat Med; 2021 May; 40(11):2604-2612. PubMed ID: 33660319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers.
    Giardina F; Romero-Severson EO; Axelsson M; Svedhem V; Leitner T; Britton T; Albert J
    Int J Epidemiol; 2019 Dec; 48(6):1795-1803. PubMed ID: 31074780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: "Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data".
    Cole SR; Chu H
    Am J Epidemiol; 2007 Oct; 166(7):861-2. PubMed ID: 17709327
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmented cross-sectional prevalence testing for estimating HIV incidence.
    Wang R; Lagakos SW
    Biometrics; 2010 Sep; 66(3):864-74. PubMed ID: 19912174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an antibody avidity index method for detecting recent human immunodeficiency virus type 1 infection using an automated chemiluminescence immunoassay.
    Fernández G; Manzardo C; Montoliu A; Campbell C; Fernández G; Casabona J; Miró JM; Matas L; Rivaya B; González V
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):238-42. PubMed ID: 25060663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.
    Laeyendecker O; Konikoff J; Morrison DE; Brookmeyer R; Wang J; Celum C; Morrison CS; Abdool Karim Q; Pettifor AE; Eshleman SH
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29489059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new general biomarker-based incidence estimator.
    Kassanjee R; McWalter TA; Bärnighausen T; Welte A
    Epidemiology; 2012 Sep; 23(5):721-8. PubMed ID: 22627902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.